![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-desktop-headergif-72716.gif)
![EuroAPI Header](https://www.pharmacompass.com/image/flap/euroapi-w34-mob-headergif-95876.gif)
1. 3',4',7-trihydroxyethylrutin
2. 3',4',7-tris(o-(2- Hydroxyethyl))rutin
3. Oxerutin
4. Paroven
5. Posorutin
6. Relvene
7. Rhoflux
8. Teboven
9. Troxrutine Mazal
10. Troxerutin-ratiopharm
11. Troxeven
12. Vastribil
13. Veinamitol
14. Veniten Retard
15. Veno Sl
16. Venorutin
17. Venoruton
18. Venoruton P4
19. Venotrulan Trox
20. Vitamin P4
1. 7085-55-4
2. Posorutin
3. Troxerutine
4. Vitamin P4
5. Venoruton P4
6. Trioxyethylrutin
7. Trihydroxyethylrutin
8. 3',4',7-tris(hydroxyethyl)rutin
9. Factor P-zyma
10. Rufen-p4
11. Tris(hydroxyethyl)rutin
12. Tris(hydroxyethyl)rutoside
13. Troxerutin (inn)
14. Z 6000
15. 7y4n11pxo8
16. Nsc-758937
17. Pherarutin
18. Vastribil
19. Veinamitol
20. Troxerutin [inn]
21. Z-6000
22. Veno Sl
23. 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-(((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-((((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yl)oxy)methyl)tetrahydro-2h-pyran-2-yl)oxy)-4h-chromen-4-one
24. Troksevazin
25. Troxarutin
26. Troxerutina
27. Troxerutinum
28. Helveton
29. Venaroid
30. Veniten
31. Flebil
32. Ruven
33. 3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)flavone 3-rutinoside
34. Pur-rutin
35. Veinamitol Pulver
36. 4h-1-benzopyran-4-one, 2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
37. Troxarutin-ratiopharm
38. Trihydroxyethylrutoside
39. Troxerutine [inn-french]
40. Troxerutinum [inn-latin]
41. Troxerutina [inn-spanish]
42. Unii-7y4n11pxo8
43. Troxerutin [inn:ban:dcf]
44. Venoruton Gel
45. Ccris 1798
46. Trihydroxyethylrutoside [french]
47. Triher
48. Troxerutin,(s)
49. Ncgc00095147-01
50. 2-(3,4-bis(2-hydroxyethoxy)phenyl)-5-hydroxy-7-(2-hydroxyethoxy)-3-((2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(((2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyltetrahydro-2h-pyran-2-yloxy)methyl)tetrahydro-2h-pyran-2-yloxy)-4h-chromen-4-one
51. 4h-1-benzopyran-4-one, 2-(3,4-bis(2-hydroxyethoxy)phenyl)-3-((6-o-(6-deoxy-.alpha.-l-mannopyranosyl)-.beta.-d-glucopyranosyl)oxy)-5-hydroxy-7-(2-hydroxyethoxy)-
52. Einecs 230-389-4
53. Troxerutin (85%)
54. Brn 4778232
55. 7,3',4'-tris(o-(2-hydroxyethyl)rutin
56. Troxerutin [mi]
57. Troxerutin [inci]
58. Troxerutin [mart.]
59. Dsstox_cid_25929
60. Dsstox_rid_81230
61. Troxerutin [who-dd]
62. Dsstox_gsid_45929
63. Schembl142110
64. Tris-o-(2-hydroxyethyl)rutin
65. Chembl3182320
66. Dtxsid4045929
67. Tris-o-(b-hydroxyethyl)rutoside
68. Unii-808o347b5y
69. Troxerutin [ep Monograph]
70. Hy-n0139
71. Tox21_111450
72. Mfcd00893813
73. S2369
74. Zinc85552699
75. Akos016339659
76. Succinimidyln-methylanthranilate
77. Trihydroxyethylrutin, >=80% (hplc)
78. 808o347b5y
79. Ccg-270428
80. Cs-8204
81. Db13124
82. Ks-1394
83. Nsc 758937
84. 2-(3,4-bis(2-hydroxyethoxy)phenyl)-3-((6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranosyl)oxy)-5-hydroxy-7-(2-hydroxy Ethoxy)-4h-1-benzopyran-4-one
85. 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxymethyl]oxan-2-yl]oxychromen-4-one
86. 3',4',7-tri-o-(b-hydroxyethyl)rutoside
87. Cas-7085-55-4
88. O-(beta-hydroxyethyl)-tutinosides (mixture)
89. 3,4,7-tris-o-(2-hydroxyethyl)rutin
90. D07180
91. 085t554
92. A837010
93. Brd-k73529671-001-04-5
94. O-(.beta.-hydroxyethyl)rutoside, (3',4',7)-tri-
95. Troxerutin, European Pharmacopoeia (ep) Reference Standard
96. 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-[[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-[[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyl-2-oxanyl]oxymethyl]-2-oxanyl]oxy]-1-benzopyran-4-one
97. 2-[3,4-bis(2-hydroxyethoxy)phenyl]-5-hydroxy-7-(2-hydroxyethoxy)-3-{[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-({[(2r,3r,4r,5r,6s)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxy}methyl)oxan-2-yl]oxy}-4h-chromen-4-one
98. 2-[3,4-bis(2-hydroxyethyloxy)phenyl]-7-(2-hydroxyethyloxy)-3-[(2s,3r,4s,5s,6r)-6-[[(2r,3r,4r,5r,6s)-6-methyl-3,4,5-tris(oxidanyl)oxan-2-yl]oxymethyl]-3,4,5-tris(oxidanyl)oxan-2-yl]oxy-5-oxidanyl-chromen-4-one
99. 3-[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-flavone
100. 3-[6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-delta-glucopyranoside]3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-flavone
101. 4h-1-benzopyran-4-one,2-[3,4-bis(2-hydroxyethoxy)phenyl]-3-[[6-o-(6-deoxy-a-l-mannopyranosyl)-b-d-glucopyranosyl]oxy]-5-hydroxy-7-(2-hydroxyethoxy)-
102. 55965-63-4
103. Flavone, 3,5-dihydroxy-3',4',7-tris(2-hydroxyethoxy)-, 3-(6-o-(6-deoxy-alpha-l-mannopyranosyl)-beta-d-glucopyranoside)
Molecular Weight | 742.7 g/mol |
---|---|
Molecular Formula | C33H42O19 |
XLogP3 | -2.4 |
Hydrogen Bond Donor Count | 10 |
Hydrogen Bond Acceptor Count | 19 |
Rotatable Bond Count | 15 |
Exact Mass | 742.23202911 g/mol |
Monoisotopic Mass | 742.23202911 g/mol |
Topological Polar Surface Area | 293 Ų |
Heavy Atom Count | 52 |
Formal Charge | 0 |
Complexity | 1170 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 10 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 1 |
Anticoagulants
Agents that prevent BLOOD CLOTTING. (See all compounds classified as Anticoagulants.)
C05CA04
S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355
C - Cardiovascular system
C05 - Vasoprotectives
C05C - Capillary stabilizing agents
C05CA - Bioflavonoids
C05CA04 - Troxerutin